Effect of Garcinia Kola (Heckel) on Pharmacokinetic Parameters of Rifampicin
Abstract
Most herbal products are used with prescription drugs and have been found to affect the pharmacokinetics of these prescription drugs. The effect of concurrent administration of Garcinia kola on the pharmacokinetic parameters and penetration profile of rifampicin into the lung tissues were investigated using animal model. Albino rats in group A received rifampicin 10 mg/kg alone orally; Group B and C received 100 mg/kg and 200 mg/kg of Garcinia kola extract respectively for 10 days and on day 11, rifampicin 10 mg/kg was given. Blood samples were withdrawn from each group at 0.5, 1, 2, 4, 8, 12 and 24 h time intervals respectively. Blood samples were also withdrawn from the lungs in each group after 24 h and assayed to determine the concentration of rifampicin in the lungs. Both 100 and 200 mg/kg of Garcinia kola showed reduction in the maximum concentration (Cmax), area under concentration (AUC), clearance time (ClT), and time for plasma concentration to decrease by half (t1/2) of rifampicin. Garcinia kola significantly (P = 0.01) decreased concentration of rifampicin in the lungs by 32% and 39 % respectively. Our results show that the co-administration of Garcinia kola and rifampicin impairs the bioavailability of rifampicin and its penetration into the lungs.
References
Akinmoladun, AC, Akinrinola, BL, Olaleye, MT, Farombi, EO (2015). Kolaviron, a Garcinia kola Biflavonoid Complex, Protects Against Ischemia/Reperfusion Injury: Pertinent Mechanistic Insights from Biochemical and Physical Evaluations in Rat Brain. Neurochem. Res., 40: 777–787. https://doi.org/10.1007/s11064-015-1527-z
Alabi, QK, Akomolafe, RO, Olukiran, OS, Adeyemi, WJ, Nafiu, AO, Adefisayo, MA, Omole, JG,Kajewole, DI, Odujoko, OO (2017). The Garcinia kola biflavonoid kolaviron attenuates experimental hepatotoxicity induced by diclofenac. Pathophysiology, 24:281–290. https://doi.org/10.1016/j.pathophys.2017.07.003
Altemimi, A, Lakhssassi, N, Baharlouei, A, Watson, D, Lightfoot, D (2017). Phytochemicals: Extraction, isolation, and identification of bioactive compounds from plant extracts. Plants, 6:42-93 https://doi.org/10.3390/plants6040042
Badger-Emeka LI, Hany EK, Emeka PM (2018). Evaluation of Different Fractions of Gar¬cinia kola Extracts against Multidrug Resistant Clinical Bacterial and Fungal Isolates. Pharmacogn J.;10(5):1055-60. doi : 10.5530/pj.2018.5.178
Chang KC, Leung CC, Yew WW, Ho SC and Tam CM (2004). A nested case-control study on treatment-related risk factors for early relapse of tuberculosis. Am. J. Respir. Crit. Care. Med., 170:1124–1130.
Din F, Aman W, Ullah I, Qureshi OS, Mustapha O, Shafique S,
Zeb A (2017). Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors. Int J Nanomedicine; 12: 7291–7309. doi: 10.2147/IJN.S146315
Dranca, F, Oroian, M (2016). Optimization of ultrasound-assisted extraction of total monomeric anthocyanin (TMA) and total phenolic content (TPC) from eggplant (Solanum melongena L.) peel. Ultrason. Sonochem., 3:637–646. doi: 10.1016/j.ultsonch.2015.11.008
Esimone CO, Adikwu MU, Ndu OO, Udeogaranya PO, Ezeugwu CO, Obonga W (2003). Effect of Garcinia kola seed extract on the antimicrobial properties of some antibiotics in-vitro. J. Pharmaceutic. Allied Sci. 2: 114-120
Esimone CO, Nwafor SV, Okoli CO, Chah KF, Uzuegbu DB, Chibudu C, Eche MA, Adikwu MU (2002a). In vivo evaluation of interaction between aqueous seed extract of Garcinia kola Heckel and ciprofloxacin hydrochloride, Am. J. Therap., 9:275-280
Esimone CO, Nworu CS, Adikwu MU, Odimegwu DC, Ezugwu CO (2007). The effect of a new adaptogen, Garcinia kola seed, on the bioavailability of ofloxacin in humans. Sci. Res. Essays, 2: 482-485,
Eum S (2010). Neutrophils are the predominant infected phagocytic cells in the airways of patients with active pulmonary TB. Chest, 137:122–128
Ezeigbo OR, Ejike EN, Nwachukwu I, Ejike BU (2016). Comparative Antibacterial Activ¬ity of Methanolic, Ethanolic and Aqueous Extract of Garcinia kola (Bitter kola) and Cola nitida (Kola nut). International Journal of Plant Research;6(3):53-56. doi: 10.5923/j.plant.20160603.01. Farombi EO (2011). Bitter Kola (Garcinia kola) Seeds and Hepatoprotection. In: Preedy VR, Watson RR, Patel VB eds., Nuts and Seeds in Health and Disease Prevention. Burlington, MA: Elsevier Inc., pp. 221–228.
Ibironke, G.F.; Fasanmade, A.A (2015). Analgesic and central nervous system depressant activities of kolaviron (A Garcinia kola biflavonoid complex). Afr. J. Biomed. Res., 18:217–223
Igbinoba SI, Onyeji CO, Akanmu MA, Soyinka JO, Pullela SSV, Cook JM, Nathaniel TI. Effect of Dehusked Garcinia kola Seeds on the Overall Pharmacokinetics of Quinine in Healthy Nigerian Volunteers. The Journal of Clinical Pharmacology 2014;20(20):1-7
Iwu MM and Igboko AO (1986). The flavonoids of Garcinia kola. J Natural Prod, 45: 650-651.
Jambheker SS and Breen PJ (2012). Basic Pharmacokinetics 2nd ed. Pharmaceutical Press; London, pp. 32-56
Kalu,WO, Okafor, PN, Ijeh, II, Eleazu, C (2016). Effect of kolaviron, a biflavanoid complex from Garcinia kola on some biochemical parameters in experimentally induced benign prostatic hyperplasic rats. Biomed. Pharmacother., 83: 1436–1443. https://doi.org/10.1016/j.biopha.2016.08.064
Kaplan G (2003). Mycobacterium tuberculosis growth at the cavity surface: a microenvironment with failed immunity. Infect. Immun., 71:7099–7108
Kim DH (2008). Treatment outcomes and long-term survival in patients with extensively drug-resistant tuberculosis. Am. J. Respir. Crit. Care Med., 178:1075–1082
Kjellsson MC, Via LE, Goh A, Weiner D, Low KM, Kern S, Pillai G, Barry EF and Dartois V (2012). Pharmacokinetic Evaluation of the Penetration of Anti-tuberculosis Agents in Rabbit Pulmonary Lesions. Antimicrob. Agent Chemother., 56:446-457
Konziase, B (. 2015). Protective activity of biflavanones fromGarcinia kola against Plasmodium infection. J. Ethnopharmacol, 172: 214–218 https://doi.org/10.1016/j.jep.2015.06.038
Manourová A , Leuner O , Tchoundjeu Z, Van Damme P, Verner V, Pribyl O, Lojka B (2019). Medicinal Potential, Utilization and Domestication Status of Bitter Kola (Garcinia kola Heckel) in West and Central Africa Forests, 10:124-142; doi:10.3390/f10020124
kMitchison DA and Coates AR (2004). Predictive in vitro models of the sterilizing activity of anti-tuberculosis drugs. Curr Pharm. Des., 10:3285–3295
Mohammad Y and Mohammad I (2009) Herb-drug interactions and patient counseling. Int. J. Pharm. & Pharm. Sci, 1:1
Neralla S, Glassroth J (2003). Mycobacterium tuberculosis: the treatment of active disease. Semin. Respir. Infect., 18:392-306
Nwaehujor, CO, Udegbunam, RI, Ode, JO, Udegbunam, SO (2015). Analgesic anti-inflammatory anti-pyretic activities of Garcinia hydroxybiflavanonol (GB1) from Garcinia kola. J. Korean Soc. Appl. Biol. Chem., 58:91–96. https://doi.org/10.1007/s13765-015-0011-4
Oluwatosin, A.; Tolulope, A.; Ayokulehin, K.; Patricia, O.; Aderemi, K.; Catherine, F.; Olusegun, A (2014). Antimalarial potential of kolaviron, a biflavonoid from Garcinia kola seeds, against Plasmodium berghei infection in Swiss albino mice. Asian Pac. J. Trop. Med., 7: 97–104. https://doi.org/10.1016/S1995-7645(14)60003-1G
Omotoso, GO, Ukwubile, II, Arietarhire, L, Sulaimon, F, Gbadamosi, IT (2018) Kolaviron protects the brain in cuprizone-induced model of experimental multiple sclerosis via enhancement of intrinsic antioxidant mechanisms: Possible therapeutic applications? Pathophysiology, 25: 299–306. https://doi.org/10.1016/j.pathophys.2018.04.004
Onasanwo, S.A.; Rotu, R.A (2016). Antinociceptive and anti-inflammatory potentials of kolaviron: Mechanisms of action. J. Basic Clin. Physiol. Pharmacol., 27:363–370. doi: 10.1515/jbcpp-2015-0075
Onyekwelu, J C, Olusola, J A, Stimm, B, Mosandl, R, Agbelade, A.D. (2015). Farm-level tree growth characteristics, fruit phenotypic variation and market potential assessment of three socio-economically important forest fruit tree species. Forests, Trees and Livelihoods, 24(1), 27-42. https://doi.org/10.1080/14728028.2014.942386
Onyishi IV, Chime SA, Ogudiegwu EO (2014). Formulation of novel sustained release rifampicin-loaded solid lipid microparticles based on structured lipid matrices
from Moringa oleifera. Pharm. Dev. Technol., 25:1-9
Rizvi SAA, Saleh AM (2017). Applications of nanoparticle systems in drug delivery technology. Saudi Pharmaceutical Journal; 26 (2018): 64–70
Sacchettini JC, Rubin EJ and Freundlich JS (2008). Drugs versus bugs: in pursuit of the persistent predator Mycobacterium tuberculosis. Nat. Rev. Microbiol., 6:41–52
Tchimene KM, Anaga AO, Ugwoke CEC, Ezugwu CO, Okunji C, Iwu MM (2016). Bio-flavonoids and Garcinoic Acid from Garcinia kola seeds with Promising Anti- Inflammatory Potentials. Pharmacognosy Journal;8(1):56-58. doi:10.5530/pj.2016.1.12
Terashima, K., Y. Takaya and M. Niwa, (2002). Powerful antioxidative agents based on garcinoic acid from Garcinia kola. Bioorganic. Med. Chem., 10:1619-1625.
Tshibangu, PT, Kapepula, PM, Kapinga, MJK, Lupona, HK, Ngombe, NK, Kalenda, DT, Jansen, O, Wauters, JN, Tits, M, Angenot, L, et al (2016). Fingerprinting and validation of a LC-DAD method for the analysis of biflavanones in Garcinia kola -based antimalarial improved traditional medicines. J. Pharm. Biomed. Anal.128: 382–390. doi: 10.1016/j.jpba.2016.04.042
Ulbricht C, Chao W, Costa D, Rusie-Seamon E, Weissner W and Woods J (2008). Clinical evidence of herb–drug interactions: a systematic review by the natural standard research collaboration. Curr. Drug Metab; 9:1063–1120. William Petri: Tuberculosis In Goodman and Gilman’s (ed) The pharmacological Basis of therapeutics. McGraw Hill Medical Publishing Division, 2001 10th Ed. p1277
Yasvanth Ashokraj, Kanwal Jit Kaur, Inderjit Singh, Gunjan Kohli, Shantaram Ramdoss Bhade, Manthena Varma, Shrutidevi Agrawal & Ramesh Panchagnula (2008) In Vivo Dissolution: Predominant Factor Affecting the Bioavailability of Rifampicin in its Solid Oral Dosage Forms, Clinical Research and Regulatory Affairs, 25(1):1-12.
